Yes, propranolol is absolutely contraindicated in patients with a history of asthma.
Propranolol should never be prescribed to patients with asthma due to the significant risk of severe and potentially fatal bronchospasm. This is an absolute contraindication explicitly stated in the FDA drug label 1.
Why Propranolol is Contraindicated in Asthma
Propranolol is a non-selective beta-blocker that blocks both β1 (cardiac) and β2 (bronchial) receptors. Blocking β2-receptors in the airways prevents bronchodilation and can trigger severe bronchoconstriction in patients with asthma 1. The FDA label specifically warns that propranolol "may provoke a bronchial asthmatic attack by blocking bronchodilation produced by endogenous and exogenous catecholamine stimulation of beta-receptors" 1.
Evidence of Harm
- Network meta-analysis: Propranolol (both oral and IV) was associated with significantly higher incidences of asthma attacks compared to placebo, with infusion propranolol showing a risk ratio of 10.19 (95% CI 1.29-80.41) 2
- In patients with baseline asthma history, propranolol exhibited even higher rates of asthma exacerbations 2
- Case reports: New-onset bronchial asthma has been documented following propranolol initiation, with asthma control remaining refractory to standard therapy until propranolol was discontinued 3
Clinical Pitfalls to Avoid
- Do not assume "low dose" is safe: Even initial doses can trigger severe bronchospasm
- Do not use propranolol for any indication in asthma patients: This includes hypertension, anxiety, migraine prophylaxis, or any other indication
- Non-selective beta-blockers as a class are contraindicated: This includes timolol (oral form also showed significantly increased asthma attacks) 2
Alternative Approach: Cardioselective Beta-Blockers
If a beta-blocker is absolutely necessary for a compelling cardiovascular indication in a patient with asthma:
- Use cardioselective β1-blockers only (bisoprolol, atenolol, metoprolol, nebivolol)
- These agents showed no significant increase in asthma exacerbations in observational studies 4
- The 2010 AHA guidelines note that beta-blockers should be "avoided in patients with asthma" but distinguish between non-selective and cardioselective agents 5
- Start at the lowest possible dose and monitor closely for bronchospasm
- Ensure the patient has rescue bronchodilators readily available
Evidence Supporting Cardioselective Agents
A comprehensive review found no published reports of cardioselective β1-blockers causing asthma death, and large observational studies reported no increase in asthma exacerbations with their use 4. However, even cardioselective agents should only be used when strongly indicated and no other therapeutic options exist 6.
Key Contraindications Summary
Absolute contraindications for propranolol 1:
- Bronchial asthma (current or history)
- Cardiogenic shock
- Sinus bradycardia and greater than first-degree heart block
- Known hypersensitivity to propranolol
The risk of fatal bronchospasm with non-selective beta-blockers like propranolol far outweighs any potential cardiovascular benefit in patients with asthma 6.